Formosa Pharmaceuticals

Eyenovia Inc (NASDAQ:EYEN) shares are surging Monday in response to the company’s announcement of the launch of a new FDA-approved ophthalmic drug in collaboration with Formosa Pharmaceuticals. Key Developments: Eyenovia and Formosa Pharma have launched APP13007 (Clobetasol Propionate...